HIS
KYNB

Harvest Investment Services’s Kyntra Bio KYNB Stock Holding History

Harvest Investment Services’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-805
Closed -$375K – 171
2023
Q1 		$375K Buy
+805
New +$426K 0.29% 78

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harvest Investment Services's KYNB Position: Q2 2023 in Review

Harvest Investment Services sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 805 shares — an estimated $375K sold.

Harvest Investment Services first reported a position in KYNB in Q1 2023 and held it in 1 quarter. The position peaked at $375K in Q1 2023. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Harvest Investment Services reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Harvest Investment Services sold 805 Kyntra Bio shares in Q2 2023, an estimated $375K.
  • Harvest Investment Services first reported a position in Kyntra Bio in Q1 2023 and held it in 1 quarter.
  • Harvest Investment Services's Kyntra Bio position peaked at $375K in Q1 2023.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Harvest Investment Services's 13F filing for Q2 2023, filed 11 Aug 2023.